Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4–10) and modified to enhance molecular stability. It has been developed for laboratory research focused on neuropeptide signaling and central nervous system pathways.
In experimental settings, Semax is studied for its interaction with neurotrophic signaling mechanisms, synaptic plasticity pathways, and neuromodulatory processes. Its short peptide length and resistance to enzymatic degradation make it suitable for controlled in vitro and preclinical research.
Semax is supplied in lyophilized (freeze-dried) form to preserve molecular integrity during storage and transport.
For research purposes only. Not for human consumption.
| Specification |
Detail |
| Compound Name |
Semax |
| Classification |
Synthetic neuropeptide |
| Peptide Type |
Linear heptapeptide |
| Molecular Formula |
C₃₇H₅₁N₉O₁₀ |
| Molecular Weight |
~813.85 g/mol |
| Amino Acid Length |
7 amino acids |
| Purity |
≥99% (HPLC verified) |
| Form |
Lyophilized powder |
| Quantity |
10 mg per vial |
| Solubility |
Soluble in aqueous solutions (research handling) |
| Testing |
HPLC / MS |
| COA |
Available per batch |
| Storage |
Store refrigerated (2–8 °C) or frozen for long-term stability |
| CAS Number |
80714-61-0 |
